Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian
Are you a perfect modern gentleman ? Not if you run in public or wear a tank top to the gym …
5/11/2025
Zohran Mamdani victory shows how to defeat rightwing populism, says UK MP
5/11/2025
Fast-rising Fiji carry a nation’s pride in redemption match with England
5/11/2025
My chilling week on Roblox : sexually assaulted and shat on as a child avatar roaming the online world
5/11/2025
Jess Cartner-Morley on fashion : introducing the twinset 2.0 – where practicality meets panache
5/11/2025
‘Green desert’ : the farmers winning a battle with Brazil’s wood-pulp giant
5/11/2025